Thyroid dermopathy—A diagnostic clue of hidden hyperthyroidism

Dermato-Endocrinology

Volumn 6, Issue 1, 2014, Pages

  Dhali, Tapan Kumar ^a   Chahar, Monica ^a  

^a DR RAM MANOHAR LOHIA HOSPITAL   (India)

Author keywords

Graves disease; Hyperthyroidism; Mucin; Pretibial myxedema; Thyroid dermopathy

Indexed keywords

CARBIMAZOLE; MUCIN; TRIAMCINOLONE;

ADULT; ATROPHY; CASE REPORT; GRAVES DISEASE; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; HYPERTHYROIDISM; MALE; PALPATION; PUNCH BIOPSY; REVIEW; SKIN DISEASE; SKIN EXAMINATION; THYROID DERMOPATHY; THYROID FUNCTION TEST;

EID: 84931863474     PISSN: 19381972     EISSN: 19381980     Source Type: Journal    
DOI: 10.4161/19381980.2014.981078     Document Type: Review

References (20)

1. Cannavo SP, Borgia F, Vaccaro M, Guarneri F, Magliolo E, Guarneri B. Pretibial myxoedema associated with Hashimoto's thyroiditis. J Eur Acad Dermatol Venereol 2002; 16:625-7; PMID:12482050; http:// dx.doi.org/10.1046/j.1468-3083.2002.00532.x
2. Fatourechi V, Pajouhi M, Fransway AF. Dermopathy of Grave's disease (pretibial myxedema). Review of 150 cases. Medicine (Baltimore). 1994; 73:1-7; PMID:8309359
3. Kriss JP. Pathogenesis and treatment of pretibial myxedema. Endocrinol Metab Clin North Am 1987; 16:409-15; PMID:3319589
4. Omohundro C, Dijkstra J, Camisa C, Bergfeld W. Early onset pretibial myxedema in the absence of ophthalmopathy: a morphologic evolution. Cutis 1996; 58: 211-4; PMID:8886536
5. Schwartz KM, Fatourechi V, Ahmed DD, Pond GR. Dermopathy of Graves' disease (pretibial myxedema): long-term outcome. J Clin Endocrinol Metab 2002; 87 (2):438-446; PMID:11836263
6. Beierwaltes WH. Clinical correlation of pretibial myxedema with malignant exophthalmos. Ann Intern Med 1954; 40:968-84; PMID:13159071; http://dx.doi.org/ 10.7326/0003-4819-40-5-968
7. Davies T, Marians R, Latif R. The TSH receptor reveals itself. J Clin Invest 2002; 110 (2):161-4; PMID:12122107; http://dx.doi.org/10.1172/JCI0216234
8. Nagayama Y, Kaufman KD, Seto P, Rapoport B. Molecular cloning, sequence and functional expression of the cDNA for the human thyrotropin receptor. Biochem Biophys Res Commun 1989; 165(3):1184-90; PMID:2558651; http://dx.doi.org/10.1016/0006-291X(89)92727-7
9. Schermer DR, Roenigk HH Jr, Schumacher OP, McKenzie JM. Relationship of long-acting thyroid stimulator to pretibial myxedema. Arch Dermatol 1970; 102:62-7; PMID:4925011; http://dx.doi.org/ 10.1001/archderm.1970.04000070064009
10. Matzinger P. An innate sense of danger. Semin Immunol 1998; 10(5):399-415; PMID:9840976; http://dx. doi.org/10.1006/smim.1998.0143
11. Gitter DG, Sato K. Localized hyperhidrosis in pretibial myxedema. J Am Acad Dermatol 1990; 23:250-4; PMID:2212121; http://dx.doi.org/10.1016/0190-9622(90)70207-X
12. Kato N, Ueno H, Matsubara M. A case report of EMO syndrome showing localized hyperhidrosis in pretibial myxedema. J Dermatol 1991; 18(10):598-604; PMID:1791240
13. Gitter DG, Sato K. Localized hyperhidrosis in pretibial myxedema. J Am Acad Dermatol 1990; 23(2 Pt 1):250-4; PMID:2212121; http://dx.doi.org/10.1016/ 0190-9622(90)70207-X
14. Siegler M, Refetoff S. Pretibial myxedema: a reversible cause of foot drop due to entrapment of the peroneal nerve. N Engl J Med 1976; 294 (25):1383-4; PMID:1264177; http://dx.doi.org/10.1056/ NEJM197606172942507
15. Rapoport B, Alsabeh R, Aftergood D, McLachlan SM. Elephantiasic pretibial myxedema: insight into and a hypothesis regarding the pathogenesis of the extrathyroidal manifestations of Graves' disease. Thyroid 2000; 10 (8):685-92; PMID:11014313; http://dx. doi.org/10.1089/10507250050137761
16. Ishii M, Nakagawa K, Hamada T. An ultrastructural study of pretibial myxedema utilizing improved ruthenium red stain. J Cutan Pathol 1984; 11(2):125-31; PMID:6203946; http://dx.doi.org/10.1111/j.1600-0560.1984.tb00362.x
17. Heymann W. Advances in cutaneous manifestations of thyroid disease. Int J Dermatol 1997; 36:641-5; PMID:9352401; http://dx.doi.org/10.1046/j.1365-4362.1997.00321.x
18. Antonelli A, Navarranne A, Palla R, Alberti B, Saracino A, Mestre C, Roger P, Agostini S, Baschieri L. Pretibial myxedema and high-dose intravenous immunoglobulin treatment. Thyroid 1994; 4:399-408; PMID:7711502; http://dx.doi.org/10.1089/thy.1994.4.399
19. Dandona P, Marshall NJ, Bidey SP, Nathan A, Havard CW, 1979 Successful treatment of exophthalmos and pretibial myxoedema with plasmapheresis. Br Med J 1979; 1(6160):374-6; PMID:581653; http://dx.doi. org/10.1136/bmj.1.6160.374
20. Kuzuya N, DeGroot LJ. Effect of plasmapheresis and steroid treatment on thyrotropin binding inhibitory immunoglobulins in a patient with exophthalmos and a patient with pretibial myxedema. J Endocrinol Invest 1982; 5(6):373-8; PMID:6132943; http://dx.doi.org/ 10.1007/BF03350535